Suppr超能文献

基于索赔数据的算法用于识别严重过敏反应和颌骨坏死的有效性。

The Validity of Claims-Based Algorithms to Identify Serious Hypersensitivity Reactions and Osteonecrosis of the Jaw.

作者信息

Wright Nicole C, Curtis Jeffrey R, Arora Tarun, Smith Wilson K, Kilgore Meredith L, Saag Kenneth G, Safford Monika M, Delzell Elizabeth S

机构信息

Department of Epidemiology, University of Alabama at Birmingham, Birmingham, Alabama, United States of America.

Department of Medicine, Division of Clinical Immunology & Rheumatology, University of Alabama at Birmingham, Birmingham, Alabama, United States of America.

出版信息

PLoS One. 2015 Jul 10;10(7):e0131601. doi: 10.1371/journal.pone.0131601. eCollection 2015.

Abstract

Validation of claims-based algorithms to identify serious hypersensitivity reactions and osteonecrosis of the jaw has not been performed in large osteoporosis populations. The objective of this project is to estimate the positive predictive value of the claims-based algorithms in older women with osteoporosis enrolled in Medicare. Using the 2006-2008 Medicare 5% sample data, we identified potential hypersensitivity and osteonecrosis of the jaw cases based on ICD-9 diagnosis codes. Potential hypersensitivity cases had a 995.0, 995.2, or 995.3 diagnosis code on emergency department or inpatient claims. Potential osteonecrosis of the jaw cases had ≥1 inpatient or outpatient physician claim with a 522.7, 526.4, 526.5, or 733.45 diagnosis code or ≥2 claims of any type with a 526.9 diagnosis code. All retrieved records were redacted and reviewed by experts to determine case status: confirmed, not confirmed, or insufficient information. We calculated the positive predictive value as the number of confirmed cases divided by the total number of retrieved records with sufficient information. We requested 412 potential hypersensitivity and 304 potential osteonecrosis of the jaw records and received 174 (42%) and 84 (28%) records respectively. Of 84 potential osteonecrosis of the jaw cases, 6 were confirmed, resulting in a positive predictive value (95% CI) of 7.1% (2.7, 14.9). Of 174 retrieved potential hypersensitivity records, 95 were confirmed. After exclusion of 25 records with insufficient information for case determination, the overall positive predictive value (95% CI) for hypersensitivity reactions was 76.0% (67.5, 83.2). In a random sample of Medicare data, a claim-based algorithm to identify serious hypersensitivity reactions performed well. An algorithm for osteonecrosis of the jaw did not, partly due to the inclusion of diagnosis codes that are not specific for osteoporosis of the jaw.

摘要

在大量骨质疏松症患者群体中,尚未对基于索赔数据的算法识别严重过敏反应和颌骨坏死的有效性进行验证。本项目的目的是评估基于索赔数据的算法在参加医疗保险的老年骨质疏松症女性中的阳性预测值。利用2006 - 2008年医疗保险5%抽样数据,我们根据国际疾病分类第九版(ICD - 9)诊断编码识别潜在的过敏反应和颌骨坏死病例。潜在过敏反应病例在急诊科或住院索赔中有995.0、995.2或995.3诊断编码。潜在颌骨坏死病例有≥1次住院或门诊医生索赔,诊断编码为522.7、526.4、526.5或733.45,或≥2次任何类型的索赔,诊断编码为526.9。所有检索到的记录都经过编辑并由专家审查以确定病例状态:确诊、未确诊或信息不足。我们将阳性预测值计算为确诊病例数除以有足够信息的检索记录总数。我们请求获取412例潜在过敏反应和304例潜在颌骨坏死记录,分别收到174例(42%)和84例(28%)记录。在84例潜在颌骨坏死病例中,6例确诊,阳性预测值(95%置信区间)为7.1%(2.7,14.9)。在174例检索到的潜在过敏反应记录中,95例确诊。在排除25例因信息不足无法确定病例的记录后,过敏反应的总体阳性预测值(95%置信区间)为76.0%(67.5,83.2)。在医疗保险数据的随机样本中,基于索赔数据的算法识别严重过敏反应的表现良好。而用于识别颌骨坏死的算法表现不佳,部分原因是纳入了并非颌骨骨质疏松症特异性的诊断编码。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1218/4498926/3850a971cc75/pone.0131601.g001.jpg

相似文献

1
The Validity of Claims-Based Algorithms to Identify Serious Hypersensitivity Reactions and Osteonecrosis of the Jaw.
PLoS One. 2015 Jul 10;10(7):e0131601. doi: 10.1371/journal.pone.0131601. eCollection 2015.
5
Evaluation of an ICD-10 algorithm to detect osteonecrosis of the jaw among cancer patients in the Danish National Registry of Patients.
Pharmacoepidemiol Drug Saf. 2015 Jul;24(7):693-700. doi: 10.1002/pds.3786. Epub 2015 May 14.
6
Evaluation of three algorithms to identify incident breast cancer in Medicare claims data.
Health Serv Res. 2007 Oct;42(5):2056-69. doi: 10.1111/j.1475-6773.2007.00705.x.

引用本文的文献

1
Medication-Related Osteonecrosis of the Jaw in Cancer Patients: Result from the OneFlorida Clinical Research Consortium.
J Bone Miner Res. 2022 Dec;37(12):2466-2471. doi: 10.1002/jbmr.4708. Epub 2022 Oct 5.
2
Assessment of a Claims-Based ICD-9 and ICD-10 Medication-Related Osteonecrosis of the Jaw Algorithm in the United States.
Clin Epidemiol. 2021 Oct 28;13:1019-1026. doi: 10.2147/CLEP.S325080. eCollection 2021.

本文引用的文献

5
Atypical femoral diaphyseal and subtrochanteric fractures and their association with bisphosphonates.
BMJ Case Rep. 2009;2009. doi: 10.1136/bcr.10.2008.1073. Epub 2009 Mar 5.
7
Bisphosphonate adverse effects, lessons from large databases.
Curr Opin Rheumatol. 2010 Jul;22(4):404-9. doi: 10.1097/BOR.0b013e32833ad677.
8
Bisphosphonates and time to osteonecrosis development.
Oncologist. 2009 Nov;14(11):1154-66. doi: 10.1634/theoncologist.2009-0115. Epub 2009 Nov 8.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验